Exact Mass: 358.0083606

Exact Mass Matches: 358.0083606

Found 17 metabolites which its exact mass value is equals to given mass value 358.0083606, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

MPTA

4-(N-Maleimido)phenyltrimethylammonium iodide

C13H15N2O2. I (358.017824)


   

2-Iodomelatonin

N-[2-(2-Iodo-5-methoxy-1H-indol-3-yl)ethyl]ethanimidate

C13H15IN2O2 (358.01782399999996)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

N-Iodo-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide

N-Iodo-N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide

C13H15IN2O2 (358.01782399999996)


   
   
   

tert-Butyl 3-iodo-5-methyl-1H-pyrrolo[2,3-b]pyridine-1-carboxylate

tert-Butyl 3-iodo-5-methyl-1H-pyrrolo[2,3-b]pyridine-1-carboxylate

C13H15IN2O2 (358.01782399999996)


   

1-[(4-chlorophenyl)methyl]-3-(3,4-dichlorophenyl)-1-methoxyurea

1-[(4-chlorophenyl)methyl]-3-(3,4-dichlorophenyl)-1-methoxyurea

C15H13Cl3N2O2 (358.0042568)


   

Mifobate

Mifobate

C11H17ClO7P2 (358.0138022)


C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C154291 - Peroxisome Proliferator-Activated Receptor Agonist Mifobate (SR-202) is a potent and specific PPARγ antagonist. Mifobate (SR-202) selectively inhibits Thiazolidinedione (TZD)-induced PPARγ transcriptional activity (IC50=140 μM). Mifobate (SR-202) does not affect basal or ligand-stimulated transcriptional activity of PPARα, PPARβ, or the farnesoid X receptor (FXR). Mifobate (SR-202) shows antiobesity and antidiabetic effects[1].

   

TETRAKIS(ACETONITRILE)SILVER(I) TETRAFLUOROBORATE

TETRAKIS(ACETONITRILE)SILVER(I) TETRAFLUOROBORATE

C8H12AgBF4N4 (358.01420399999995)


   

2-(3,4-Dichlorophenoxy)-6-(4-fluorophenyl)pyridine-3-carbonitrile

2-(3,4-Dichlorophenoxy)-6-(4-fluorophenyl)pyridine-3-carbonitrile

C18H9Cl2FN2O (358.00759359999995)


   

1-(4-Bromo-3-ethoxyphenyl)sulfonyl-3,5-dimethylpyrazole

1-(4-Bromo-3-ethoxyphenyl)sulfonyl-3,5-dimethylpyrazole

C13H15BrN2O3S (357.99867000000006)


   

N-(4-bromo-3-chlorophenyl)-5-oxo-1-propan-2-yl-3-pyrrolidinecarboxamide

N-(4-bromo-3-chlorophenyl)-5-oxo-1-propan-2-yl-3-pyrrolidinecarboxamide

C14H16BrClN2O2 (358.0083606)


   

4-(N-Maleimido)phenyltrimethylammonium iodide

4-(N-Maleimido)phenyltrimethylammonium iodide

C13H15IN2O2 (358.01782399999996)


   

2-Iodomelatonin

2-Iodomelatonin

C13H15IN2O2 (358.01782399999996)


D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones

   

7-hydroxy-11-(hydroxymethyl)-16-methyl-12,13,14-trithia-9,16-diazatetracyclo[9.3.2.0¹,⁹.0³,⁸]hexadeca-3,5-diene-10,15-dione

7-hydroxy-11-(hydroxymethyl)-16-methyl-12,13,14-trithia-9,16-diazatetracyclo[9.3.2.0¹,⁹.0³,⁸]hexadeca-3,5-diene-10,15-dione

C13H14N2O4S3 (358.01156840000004)


   

(1r,7s,8s,11r)-7-hydroxy-11-(hydroxymethyl)-16-methyl-12,13,14-trithia-9,16-diazatetracyclo[9.3.2.0¹,⁹.0³,⁸]hexadeca-3,5-diene-10,15-dione

(1r,7s,8s,11r)-7-hydroxy-11-(hydroxymethyl)-16-methyl-12,13,14-trithia-9,16-diazatetracyclo[9.3.2.0¹,⁹.0³,⁸]hexadeca-3,5-diene-10,15-dione

C13H14N2O4S3 (358.01156840000004)